Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosis.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
27 01 2021
Historique:
received: 03 05 2020
accepted: 04 01 2021
entrez: 28 1 2021
pubmed: 29 1 2021
medline: 4 2 2021
Statut: epublish

Résumé

Mycobacterium tuberculosis (Mtb) exposure drives antibody responses, but whether patients with active tuberculosis elicit protective antibodies, and against which antigens, is still unclear. Here we generate monoclonal antibodies from memory B cells of one patient to investigate the B cell responses during active infection. The antibodies, members of four distinct B cell clones, are directed against the Mtb phosphate transporter subunit PstS1. Antibodies p4-36 and p4-163 reduce Mycobacterium bovis-BCG and Mtb levels in an ex vivo human whole blood growth inhibition assay in an FcR-dependent manner; meanwhile, germline versions of p4-36 and p4-163 do not bind Mtb. Crystal structures of p4-36 and p4-170, complexed to PstS1, are determined at 2.1 Å and 2.4 Å resolution, respectively, to reveal two distinctive PstS1 epitopes. Lastly, a prophylactic p4-36 and p4-163 treatment in Mtb-infected Balb/c mice reduces bacterial lung burden by 50%. Our study shows that inhibitory anti-PstS1 B cell responses arise during active tuberculosis.

Identifiants

pubmed: 33504803
doi: 10.1038/s41467-021-20930-0
pii: 10.1038/s41467-021-20930-0
pmc: PMC7840946
doi:

Substances chimiques

Antibodies, Bacterial 0
Antibodies, Monoclonal 0
Bacterial Proteins 0
Epitopes 0
Membrane Transport Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

602

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 207487/C/17/Z
Pays : United Kingdom

Références

PLoS One. 2008 Jun 11;3(6):e2375
pubmed: 18584054
Science. 2003 Sep 5;301(5638):1374-7
pubmed: 12920303
J Infect Dis. 2016 Jul 15;214(2):300-10
pubmed: 27056953
Tuberculosis (Edinb). 2015 Jun;95 Suppl 1:S177-89
pubmed: 25797613
BMC Res Notes. 2017 Jan 23;10(1):59
pubmed: 28114976
EMBO Mol Med. 2016 Nov 2;8(11):1325-1339
pubmed: 27729388
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Nat Rev Dis Primers. 2016 Oct 27;2:16076
pubmed: 27784885
J Immunol. 2011 Mar 1;186(5):3113-9
pubmed: 21257971
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
J Exp Med. 2014 Nov 17;211(12):2361-72
pubmed: 25385756
J Immunol Methods. 2009 Apr 15;343(2):65-7
pubmed: 19100741
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Cell Host Microbe. 2015 Nov 11;18(5):538-48
pubmed: 26607161
Clin Exp Immunol. 1989 Sep;77(3):373-7
pubmed: 2478322
PLoS Pathog. 2016 Jun 15;12(6):e1005687
pubmed: 27304615
Front Immunol. 2019 Sep 11;10:1968
pubmed: 31572351
J Microbiol Methods. 2017 Jan;132:134-138
pubmed: 27940201
PLoS One. 2012;7(9):e46041
pubmed: 23029377
Nat Microbiol. 2016 Aug 26;1(11):16147
pubmed: 27564922
Sci Transl Med. 2017 Jan 18;9(373):
pubmed: 28100831
Proc Natl Acad Sci U S A. 2017 May 9;114(19):5023-5028
pubmed: 28438994
Microbes Infect. 2012 Sep;14(11):959-67
pubmed: 22546526
J Immunol Methods. 2015 Mar;418:61-5
pubmed: 25667013
Tuberculosis (Edinb). 2008 Jul;88(4):366-70
pubmed: 18068490
J Immunol. 1997 Jun 15;158(12):5921-6
pubmed: 9190945
J Immunol Methods. 2008 Jan 1;329(1-2):112-24
pubmed: 17996249
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Science. 2011 Sep 16;333(6049):1633-7
pubmed: 21764753
Front Immunol. 2019 May 09;10:996
pubmed: 31143177
Nat Rev Immunol. 2018 Sep;18(9):591-596
pubmed: 29872140
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Infect Immun. 2005 Mar;73(3):1898-902
pubmed: 15731097
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
Cell. 2016 Oct 6;167(2):433-443.e14
pubmed: 27667685
PLoS Pathog. 2015 Oct 30;11(10):e1005238
pubmed: 26516768
Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):E3268-77
pubmed: 23115339
Acta Crystallogr D Biol Crystallogr. 2013 Jul;69(Pt 7):1204-14
pubmed: 23793146
Nat Genet. 2010 Jun;42(6):498-503
pubmed: 20495566
PLoS One. 2017 Aug 2;12(8):e0180122
pubmed: 28767658
Nat Commun. 2016 Apr 12;7:11290
pubmed: 27068708
Pediatrics. 1998 Sep;102(3 Pt 1):531-7
pubmed: 9738173
Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6181-6
pubmed: 22474370
Nat Med. 2019 Jun;25(6):977-987
pubmed: 31110348
Nature. 2019 Jun;570(7762):528-532
pubmed: 31168092
J Exp Med. 2000 Aug 7;192(3):347-58
pubmed: 10934223
Sci Rep. 2019 Feb 28;9(1):3042
pubmed: 30816178
N Engl J Med. 2017 Jan 19;376(3):283-285
pubmed: 28099836

Auteurs

Avia Watson (A)

Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.

Hao Li (H)

Centre for Global Health and Infectious Diseases, Collaborative Innovation Centre for the Diagnosis and Treatment of Infectious Diseases, Tsinghua University School of Medicine, Beijing, China.
College of Veterinary Medicine, China Agricultural University, Beijing, China.

Bingting Ma (B)

Advanced Innovation Center for Structural Biology & Beijing Frontier Research Center for Biological Structure, Tsinghua University School of Medicine, Beijing, China.

Ronen Weiss (R)

Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.

Daniele Bendayan (D)

Pulmonary and Tuberculosis Department, Shmuel Harofe Hospital, Be'er Ya'akov, Israel.

Lilach Abramovitz (L)

Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.

Noam Ben-Shalom (N)

Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.

Michael Mor (M)

Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.

Erica Pinko (E)

Pulmonary and Tuberculosis Department, Shmuel Harofe Hospital, Be'er Ya'akov, Israel.

Michal Bar Oz (M)

Koret School of Veterinary Medicine, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot, Israel.

Zhenqi Wang (Z)

Centre for Global Health and Infectious Diseases, Collaborative Innovation Centre for the Diagnosis and Treatment of Infectious Diseases, Tsinghua University School of Medicine, Beijing, China.

Fengjiao Du (F)

Beijing Key Laboratory of Drug Resistance Tuberculosis Research, Department of Pharmacology, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.

Yu Lu (Y)

Beijing Key Laboratory of Drug Resistance Tuberculosis Research, Department of Pharmacology, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.

Jan Rybniker (J)

Department of Internal Medicine, Division of Infectious Diseases, University of Cologne, Cologne, Germany.
German Center for Infection Research (DZIF), Bonn-Cologne, Germany.

Rony Dahan (R)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

Hairong Huang (H)

National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.

Daniel Barkan (D)

Koret School of Veterinary Medicine, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot, Israel.

Ye Xiang (Y)

Advanced Innovation Center for Structural Biology & Beijing Frontier Research Center for Biological Structure, Tsinghua University School of Medicine, Beijing, China. yxiang@mail.tsinghua.edu.cn.

Babak Javid (B)

Centre for Global Health and Infectious Diseases, Collaborative Innovation Centre for the Diagnosis and Treatment of Infectious Diseases, Tsinghua University School of Medicine, Beijing, China. bjavid@gmail.com.
Division of Experimental Medicine, University of California, San Francisco, CA, USA. bjavid@gmail.com.

Natalia T Freund (NT)

Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel. nfreund@tauex.tau.ac.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH